维普期刊资源整合服务平台（V6.5）

135篇 您的检索式：作者名="Loberg"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	抗体偶联药物质量控制和临床前评价专家共识显示文摘抗体偶联药物,即ADC(Antibody-Drug conjugate),是通过连接子(linker)将具有生物活性的小分子药物偶联至单克隆抗体(单抗)上而产生的。目前,绝大部分ADC是由靶向肿瘤抗原的抗体通过连接子与高效细胞毒性的小分子化学药物偶联而成。	王兰郭莎于传飞王文波付志浩霍艳王欣耿兴超刘丽文海若陈琰 Christopher Yu 蔺亚萌方言房健民姚雪静李新芳5 胡朝红杨敬 Lise Loberg	2018	中国药事2018，32，7：	9
2	Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline显示文摘	Cesare Hassan Enrique Quintero Jean-Marc Dumonceau Jaroslaw Regula Catarina Brand?o Stanislas Chaussade Evelien Dekker Mario Dinis-Ribeiro Monika Ferlitsch Antonio Gimeno-García Yark Hazewinkel Rodrigo Jover Mette Kalager Magnus Loberg Christian Pox Bjorn	2013	Endoscopy2013，，10：	3
3	CCL2 is a potent regulator of prostate cancer cell migration and proliferation 显示文摘	Loberg RD Day LL Harwood J	2006	Neoplasia2006，8，7：	1
4	A gsk-3/tsc2/mtor pathway regulates glucose uptake and glut1 glucose transporter expression显示文摘	Buller CL Loberg RD Fan MH	2008	Am J Physiol Cell Physiol2008，295，3：	1
5	Hemispheric asymmetry in schizophrenia: a 'dual deficits' model显示文摘	Loberg E M Hugdahl K Green M F	1999	Biological Psychiatry1999，45，1：	1
6	PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells显示文摘	Loberg RD Tantivejkul K Craig M et	2007	J Cell Biochem2007，101，5：	1
7	The pivotal role of CXCL12(SDF-1)/CXCR4 axis in bone metastasis显示文摘	Wang J Loberg R Taichman RS	2006	Cancer Metastasis Rev2006，25，4：	1
8	Post-hypoxic-ischemic hypothermin reduces necrosis and apoptosis correspondingly in the newborn rat however restraint stress ameliorates neuroprotection显示文摘	Thoresen M Apricena F Loberg EM	1998	Pediatr Res1998，44，3：	1
9	The lethal phenotype of cancer:the molecular basis of death due to malignancy显示文摘	Loberg RD Bradley DA Tomlins SA	2007	CA Cancer J Clin2007，57，4：	1
10	Differential expression analysis of MIM ( MTSS1 ) splice variants and a functional role of MIM in prostate cancer cell biology显示文摘	Loberg RD Neeley CK Adam-Day LL	2005	Int J Oncol2005，26，6：	1
11	Women with newly diagnosed breast cancer and their perceptions of needs in a health-care context显示文摘	Landmark BT Bohler A Loberg K	2008	J Clin Nuts2008，17，7：	1
12	Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene,and MIM-B, in bladder cancer cell lines 显示文摘	Nixdorf S Grimm MO Loberg R	2004	Cancer Lett2004，215，2：	1
13	Expression of cancer-related genes in human cells exposed to 60 Hz magnetic fields 显示文摘	LOBERG L I ENGDAHL W R GAUGER J R	2000	Radiat Res2000，153，52：	1
14	In vivo evaluation of AT-101 (R-(-)-go ssypolacetic acid) inandrogen-independent growth of prostate cancer cells in combination with surgical castration显示文摘	Loberg RD Mcgregory N Ying C	2007	Neoplasia2007，9，：	1
15	The evolving biology and treatment of prostate cancer显示文摘	Taichman RS Loberg RD Mehra R	2007	J Clin Invest2007，117，9：	1
16	Pathogenesis and treatment of prostate cancer bone metastases:targeting the lethal phenotype显示文摘	Loberg RD Logothetis CJ Keller ET	2005	J Clin Oncol2005，23，：	1
17	Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid显示文摘	Loberg MD Cooper M Harvey E	1976	J Nucl Med1976，17，7：	1
18	Expression of bd2 and amplification of c-myc are frequent in basaloid squarnous cell carcinomas of the esophagus显示文摘	Sarbia M Loberg C Wolter M	1999	Am J Pathol1999，155，6：	1
19	Differential expres-sion analysis of MIM (MTSS1) splice variants and a functional roleof MIM in prostate cancer cell biology 显示文摘	Loberg RD Neeley CK Adam-Day LL	2005	Int J Oncol2005，26，6：	1
20	Targeting CCl2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo显示文摘	Loberg RD Ying C Craig M	2007	Cancer Res2007，67，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示